Acta Orthopaedica 2011; 82 (1): 96–101 Agarwala A K, Hanna N H. Long-term survival in a patient with stage IV non- small-cell lung carcinoma after bone metastasectomy. Clin Lung Cancer 2005; 6: 367-8. Atanasiu J P, Badatcheff F, Pidhorz L. Metastatic lesions of the cervical spine. A retrospective analysis of 20 cases. Spine (Phila Pa 1976) 1993; 18: 1279-84. Bauer H C, Wedin R. Survival after surgery for spinal and extremity metasta- ses. Prognostication in 241 patients. Acta Orthop Scand 1995; 66: 143-6. Bohm P, Huber J. The surgical treatment of bony metastases of the spine and limbs. J Bone Joint Surg (Br) 2002; 84: 521-9. Bono B, Cazzaniga P, Pini V, Zurrida S M, Spagnolo R, Torelli L, Corona C, Bono A. Palliative surgery of metastatic bone disease: a review of 83 cases. Eur J Cancer 1991; 27: 556-8. Boyle P, Dresler C. Preventing the lung cancer epidemic. Ann Oncol 2005; 16: 1565-6. Coleman R E. Skeletal complications of malignancy. Cancer 1997; 80: 1588- 94. Cybulski G R, Von Roenn K A, D’Angelo C M, DeWald R L. Luque rod stabi- lization for metastatic disease of the spine. Surg Neurol 1987; 28: 277-83. Davis L A, Warren S A, Reid D C, Oberle K, Saboe L A, Grace M G. Incom- plete neural deficits in thoracolumbar and lumbar spine fractures. Reliabil- ity of Frankel and Sunnybrook scales. Spine (Phila Pa 1976) 1993; 18: 257-63. Durr H R, Refior H J. Prognosis of skeletal metastases. Orthopade 1998, 27: 294-300. Frankel H L, Hancock D O, Hyslop G, Melzak J, Michaelis L S, Ungar G H, Vernon J D, Walsh J J. The value of postural reduction in the initial man- agement of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia 1969; 7: 179-92. Giaccone G, Gallegos Ruiz M, Le Chevalier T, Thatcher N, Smit E, Rodriguez J A, Janne P, Oulid-Aissa D, Soria J C. Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study. Clin Cancer Res 2006; 12: 6049-55. Hansen B H, Keller J, Laitinen M, Berg P, Skjeldal S, Trovik C, Nilsson J, Walloe A, Kalen A, Wedin R. The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand (Suppl 311) 2004, 75: 11-5. Harrington K D, Sim F H, Enis J E, Johnston J O, Diok H M, Gristina A G. Methylmethacrylate as an adjunct in internal fixation of pathological frac- tures. Experience with three hundred and seventy-five cases. J Bone Joint Surg (Am) 1976; 58: 1047-55. Hirano Y, Oda M, Tsunezuka Y, Ishikawa N, Watanabe G. Long-term survival cases of lung cancer presented as solitary bone metastasis. Ann Thorac Cardiovasc Surg 2005, 11: 401-4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M J. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49. 101 Katagiri H, Takahashi M, Wakai K, Sugiura H, Kataoka T, Nakanishi K. Prog- nostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg (Br) 2005; 87: 698-703. Langer C, Hirsh V. Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates. Lung Cancer 2010; 67: 4-11. Lin P P, Mirza A N, Lewis V O, Cannon C P, Tu S M, Tannir N M, Yasko A W. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg (Am) 2007; 89: 1794-801. Matzkin H, Perito P E, Soloway M S. Prognostic factors in metastatic prostate cancer. Cancer 1993; 72: 3788-92. Mountain C F. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111: 1710-7. Nathan S S, Healey J H, Mellano D, Hoang B, Lewis I, Morris C D, Atha- nasian E A, Boland P J. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol 2005; 23: 6072-82. Rosen L S, Gordon D, Tchekmedyian S, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, de Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman J J. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double- blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 2003; 21: 3150-7. Sandler A, Gray R, Perry M C, Brahmer J, Schiller J H, Dowlati A, Lilenbaum R, Johnson D H. Paclitaxel-carboplatin alone or with bevacizumab for non- small-cell lung cancer. N Engl J Med 2006; 355: 2542-50. Sugiura H, Yamada K, Sugiura T, Hida T, Mitsudomi T. Predictors of survival in patients with bone metastasis of lung cancer. Clin Orthop 2008; (466): 729-36. Tomita K, Kawahara N, Baba H, Tsuchiya H, Nagata S, Toribatake Y. Total en bloc spondylectomy for solitary spinal metastases. Int Orthop 1994; 18: 291-8. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 2001; 26: 298-306. Wedin R, Bauer H C. Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Joint Surg (Br) 2005; 87: 1653-7. Wedin R, Bauer H C, Wersall P. Failures after operation for skeletal metastatic lesions of long bones. Clin Orthop 1999: (358): 128-39. Wedin R, Bauer H C, Rutqvist L E. Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patients. Cancer 2001; 92: 257-62. Yazawa Y, Frassica F J, Chao E Y, Pritchard D J, Sim F H, Shives T C. Meta- static bone disease. A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop 1990; (251): 213-9.